« Zurück
Startseite /
RPRD1A Antibody, HRP conjugated

RPRD1A Antibody, HRP conjugated

ArtNr	CSB-PA850404LB01HU-50ug
Hersteller	Cusabio
Menge	50 ug
Quantity options	100 ug 50 ug
Kategorie	Oncology Neuroscience Neural Lineage Markers Antibodies By Cell Type Blastoma Carcinoma Cell Biology Cell Status ELISA Proliferation Primary Antibodies By Organ Bladder Cancer Immunostaining
Typ	Antibody Polyclonal
Format	Liquid
Applikationen	ELISA
Specific against	Human (Homo sapiens)
Host	Rabbit
Isotype	IgG
Konjugat/Tag	HRP
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Alias	C77387 antibody,CDKN2B-related protein antibody,Cyclin dependent kinase 2B inhibitor related protein antibody,Cyclin dependent kinase inhibitor 2B related protein (p15INK4B related protein) antibody,Cyclin dependent kinase inhibitor 2B related protein antibody,Cyclin dependent kinase inhibitor related protein antibody,Cyclin-dependent kinase inhibitor 2B-related protein antibody,FLJ10656 antibody,HsT3101 antibody,Hypothetical protein FLJ10656 antibody,KIAA4077 antibody,MGC19513 antibody,MGC29396 antibody,MGC36325 antibody,mKIAA4077 antibody,p15INK4B related protein antibody,p15INK4B-related protein antibody,Putative uncharacterized protein P15RS antibody,Regulation of nuclear pre mRNA domain containing 1A antibody,Regulation of nuclear pre-mRNA domain-containing protein 1A antibody,RGD1307374 antibody,RPR1A_HUMAN antibody,RPRD1A antibody
Similar products	RPRD1A, P15RS, Regulation of nuclear pre-mRNA domain-containing protein 1A (Cyclin-dependent kinase inhibitor 2B-related protein) (p15INK4B-related protein)
Lieferbar
Manufacturer - Type	Polyclonal Antibody
Manufacturer - Targets	RPRD1A
Storage Conditions	Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Manufacturer - Alias	C77387 antibody, CDKN2B-related protein antibody, Cyclin dependent kinase 2B inhibitor related protein antibody, Cyclin dependent kinase inhibitor 2B related protein (p15INK4B related protein) antibody, Cyclin dependent kinase inhibitor 2B related protein antibody, Cyclin dependent kinase inhibitor related protein antibody, Cyclin-dependent kinase inhibitor 2B-related protein antibody, FLJ10656 antibody, HsT3101 antibody, Hypothetical protein FLJ10656 antibody, KIAA4077 antibody, MGC19513 antibody, MGC29396 antibody, MGC36325 antibody, mKIAA4077 antibody, p15INK4B related protein antibody, p15INK4B-related protein antibody, Putative uncharacterized protein P15RS antibody, Regulation of nuclear pre mRNA domain containing 1A antibody, Regulation of nuclear pre-mRNA domain-containing protein 1A antibody, RGD1307374 antibody, RPR1A_HUMAN antibody, RPRD1A antibody
Immunogen Species	Human
Immunogen	Recombinant Human Regulation of nuclear pre-mRNA domain-containing protein 1A protein (2-276AA)
Background	Interacts with phosphorylated C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit POLR2A, and participates in dephosphorylation of the CTD. May act as a negative regulator of cyclin-D1 (CCND1) and cyclin-E (CCNE1) in the cell cycle.
Buffer	Preservative: 0.03% Proclin 300 Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
Purification Method	>95%, Protein G purified
General Research Areas	Cell Biology
Initial Research Areas	Cell Biology
Antigen Species	Human
Antigen	Recombinant Human Regulation of nuclear pre-mRNA domain-containing protein 1A protein (2-276AA)
Clonality	Polyclonal

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Arbeitsanleitung (Data Sheet) anfordern

CSB-PA850404LB01HU-50ug-datasheet.pdf

Sicherheitsdatenblatt anfordern

Einfache Bestellung Periodische Bestellung

Menge: 50 ug

lieferbar

Lieferung vsl. bis 06.11.2025